Diabetic Proteinuria Revisited: Updated Physiologic Perspectives.

Samuel N Heyman, Itamar Raz, Jamie P Dwyer, Roni Weinberg Sibony, Julia B Lewis, Zaid Abassi

Journal: Cells 2022;11(18):2917

PMID: 36139492

Abstract

Albuminuria, a hallmark of diabetic nephropathy, reflects not only injury and dysfunction of the filtration apparatus, but is also affected by altered glomerular hemodynamics and hyperfiltration, as well as by the inability of renal tubular cells to fully retrieve filtered albumin. Albuminuria further plays a role in the progression of diabetic nephropathy, and the suppression of glomerular albumin leak is a key factor in its prevention. Although microalbuminuria is a classic manifestation of diabetic nephropathy, often progressing to macroalbuminuria or overt proteinuria over time, it does not always precede renal function loss in diabetes. The various components leading to diabetic albuminuria and their associations are herein reviewed, and the physiologic rationale and efficacy of therapeutic interventions that reduce glomerular hyperfiltration and proteinuria are discussed. With these perspectives, we propose that these measures should be initiated early, before microalbuminuria develops, as substantial renal injury may already be present in the absence of proteinuria. We further advocate that the inhibition of the renin-angiotensin axis or of sodium-glucose co-transport likely permits the administration of a normal recommended or even high-protein diet, highly desirable for sarcopenic diabetic patients.

Address: Department of Medicine, Hadassah Hebrew University Hospital, Mt. Scopus, Jerusalem 9765422, Israel.; Division of Geriatrics, Herzog Hospital, Jerusalem 9765422, Israel.; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9765422, Israel.; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem 9124001, Israel.; Clinical and Translational Science Institute, University of Utah Health, Salt Lake City, UT 84112, USA.; Faculty of Medicine, Ben-Gurion University, Beer Sheva 84105, Israel.; Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Departments of Medicine and Nephrology, Vanderbilt University Medical Center, Nashville, TN 37011, USA.; Department of Physiology and Biophysics, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel.; Department of Laboratory Medicine, Rambam Health Care Campus, Haifa 3109601, Israel.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.